Acadia Pharmaceuticals | ACAD - Текущие обязательства





Текущие обязательства Изменить Дата
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
ALKERMES USD 599.5M 56.06M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Biogen USD 3B 350.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Cara Therapeutics USD 11.04M 2K 2025-12
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Cytokinetics USD 199.18M 3.27M 2026-03
Eisai JPY 340.25B 47.42B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Incyte USD 1.49B 25.52M 2026-03
J&J USD 57.72B 3.59B 2026-03
Moderna USD 2.4B 408M 2026-03
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Prothena USD 32.52M 8.33M 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03